Tiffany Clay-Ramsey, MD
Dermatology · Marietta, GANPI 1508152232
Payments from drug & device makers
Across 773 payments — averaging $267.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$154K
- Lilly USA, LLC$20K
- Janssen Scientific Affairs, LLC$18K
- Galderma Laboratories, L.p.$4K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $7K from 28 others
What the payments were for
- Consulting fees$4,1002%
- Speaking & faculty fees$161,73278%
- Travel & lodging$23,02211%
- Food & beverage$17,5388%
- Education$2290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 178 | $153,884 |
| Lilly USA, LLC | 58 | $19,719 |
| Janssen Scientific Affairs, LLC | 22 | $18,367 |
| Galderma Laboratories, L.p. | 32 | $3,723 |
| AbbVie(2 entities) | 111 | $2,398 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,502 |
| Pfizer | 87 | $1,496 |
| Mayne Pharma Commercial LLC | 35 | $617 |
| UCB, Inc. | 16 | $543 |
| Sanofi | 15 | $512 |
| LEO Pharma Inc. | 19 | $436 |
| E.r. Squibb & Sons, L.L.C. | 15 | $420 |
| Novartis | 12 | $397 |
| Arcutis Biotherapeutics, Inc. | 14 | $338 |
| Incyte Corporation | 20 | $335 |
| Sun Pharmaceutical Industries Inc. | 18 | $321 |
| Amgen | 11 | $249 |
| Almirall LLC | 10 | $224 |
| Dermavant Sciences, Inc. | 6 | $187 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $146 |
| Merck | 4 | $146 |
| Botanix SB Inc | 1 | $130 |
| Organon | 2 | $126 |
| Sanofi-aventis U.S. LLC | 1 | $84 |
| Journey Medical Corporation | 4 | $74 |
| Bristol Myers Squibb | 3 | $55 |
| EPI Health, LLC | 2 | $35 |
| Biofrontera Inc. | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| Biocon Biologics Inc | 1 | $21 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$206,621 in reported general payments places this provider in the 90th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $45,482 |
| Tacrolimus | 18 | $2,081 |
| Metronidazole | 16 | $1,202 |
| Fluorouracil | 20 | $1,123 |
| Clobetasol Propionate | 34 | $1,100 |
| Betamethasone Dipropionate | 21 | $788 |
| Ketoconazole | 39 | $495 |
| Triamcinolone Acetonide | 43 | $445 |
| Doxycycline Hyclate | 18 | $393 |
| Fluocinonide | 13 | $306 |
| Mometasone Furoate | 12 | $241 |
| Hydrocortisone | 18 | $122 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Marietta
- Anita ShettyMarietta$123K
- Onaopemipo OfodileMarietta$39K
- Edward ChenMarietta$20K
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Mark KnautzPowder Springs$1.7M
- Gerald SlagelFayetteville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.